Subject: On Target Trade

Dear Friend,

Today we bring you a brand new Trade of the Week! Each week we share a new trade idea directly from our trading team.

Terry

November 22, 2021

Week 673

On Target Trade

Target (TGT) reported earnings before the bell on Wednesday that beat estimates on both revenue and profits. The company also expects its fiscal Q4 comparable sales growth to be higher than previous forecasts. Moreover, TGT claimed the supply chain mess has not been an issue - store shelves are full and ready for the holiday buying onslaught.

Analysts were mostly bullish on the report, giving TGT several target price increases (there was one lower price). One went as high as $350, a 38% premium to Friday’s closing price. The stock price was not rewarded, however. The shares dropped 4.7% on Wednesday and slid further the rest of the week. However, this was a common theme among several retailers, including Walmart (WMT). In fact, the overall retail sector was lower for the week.

The Top 5 Stocks to Own Now for 2022

When it comes to investing, one of your top goals has been to achieve financial freedom.

So, it stands to reason your money should ideally be able to generate above-market returns with below market risk. After all, that's how real wealth is created. To help, we put together a list of five of the top stocks we believe could do quite well heading into New Year 2022.

Click Here to Download the FREE Report

The pullback dropped the shares to just above their 50-day moving average (blue line in chart). This trade is thus a bet that TGT will regain its footing and stay above the 50-day as holiday sales numbers – that are predicted to be robust – start rolling in. The short 245 strike (red line) of our put credit spread is below the 50-day, relying on trendline support to hold through expiration.

If you agree that TGT will stay atop its 50-day moving average line in chart), consider the following trade that relies on the stock remaining above 245 (through expiration in six weeks.

Buy to Open TGT 31Dec 240 put (TGT211231P240)
Sell to Open TGT 31Dec 245 put (TGT211231P245) for a credit of $1.60 (selling a vertical)

This credit is $0.02 less than the mid-point of the option spread when TGT was trading around $251. Unless the stock rises quickly from here, you should be able to get close to this amount.

Your commission on this trade will be only $1.30 per spread. Each spread would then yield $158.70. This trade reduces your buying power by $500 and makes your net investment $341.30 ($500 – $158.70) for one spread. If TGT closes above $245 on December 31, both options will expire worthless and your return on the spread would be 46% ($158.70/$341.30).

Investor Alert: "Cooling Gas Shortage" Threatens SpaceX

SpaceX (and many other tech giants) are buying up helium like crazy. And that's because the world is running out of this incredibly valuable gas! In fact, prices have already skyrocketed by 160% in the past few years...

But This Company Made A Canadian Discovery That's Changing Everything

Any questions? Email Colin@terrystips.com

Did you know that the actual 10K Strategy portfolios conducted at Terry's Tips averaged gains of over 100% in 2017, 2019, and 2020? The 10K Strategy consists of calendar and diagonal spreads which benefit from the faster decay rates of the short-term puts and calls which are sold (using longer-term options as collateral). You can learn all the details on how to carry out this strategy on your own by subscribing here. Use the Special Code D21M to pay only $98 per month vs. our regular fee of $197 (cancellable any time). Why wait any longer to make this important investment in yourself?

I look forward to having you on board, and to prospering with you.

Terry

3 Hot Biotech Breakthroughs to Bank On Now… and Why

Biotech breakthroughs by nature are part of incredibly innovative companies that are disruptors that are redefining the world we live in. And right now, the stocks working hardest toward transformational therapies… and that means some of the biggest opportunities for investors right now. In my latest research report, I share my insights on the biotech sector and give you the names of my top 3 picks.

Download your FREE copy today!

Testimonial of the Week

I've tried several "investment services" and newsletters over the last few years, but yours is the first one I really have confidence in.

~ Martin

Thank you again for being a part of the Terry's Tips newsletter. If you are interested in signing up as an Insider, visit Terry's Tips today for details.

Sincerely,

Dr. Terry Allen
Terry's Tips

Subscribe

Subject: On Target Trade

On Target Trade